01 1Aurisco Pharmaceutical
01 1BRIVARACETAM
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2022-10-11
Pay. Date : 2022-08-04
DMF Number : 37329
Submission : 2022-07-23
Status : Active
Type : II
20
Yangzhou Aurisco Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their notable products is BRIVARACETAM, with a corresponding US DMF Number 37329.
Remarkably, this DMF maintains an Active status since its submission on July 23, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 11, 2022, and payment made on August 04, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II
